Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project
-
Equinor ASA: Share buy-back
-
ArcelorMittal Announces Pricing of Bond Issue
-
Tajikistan – Aprelevka Update
-
Progress on share buyback programme
-
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape
-
TR-1: Standard form for notification of major holdings - BOUSSARD & GAVAUDAN HOLDING LIMITED
-
-
Essential Pharma reaches agreement with AGC Biologics for late phase clinical manufacturing of its immunotherapy candidate for the treatment of high-risk neuroblastoma
-
Transaction in Own Shares
-
Falcon Oil & Gas Ltd. - Investor Q&A and Additional Financing Disclosure
-
KBC Group: Update regarding the KBC Group share buyback programme
-
Ibanera Launches FedNow for Real-Time Payments Across the US
-
WENDEL: Wendel Growth invests in YesWeHack, a leading Bug Bounty and Vulnerability Management Platform
-
GRITSTONE BIO, INC. (NASDAQ: GRTS) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Gritstone bio, Inc.
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Viridien wins 20 MUSD contract to supply a Sercel GPR300 OBN solution for North Sea project
-
Nykode Therapeutics Announces mRNA-LNP Cancer Vaccine Demonstrates Superior Efficacy
-
Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
-
Feutune Light Acquisition Corporation Announces that It Will Adjourn the Special Meeting of Stockholders to Approve Business Combination with Thunder Power Holdings Limited to June 17, 2024
-
Start of Day Message
-
Market Update - June 11, 2024
-
Dassault Systèmes: Valeo partners with Dassault Systèmes to accelerate the digitalization of its R&D
-
Ultimovacs provides update from Phase I study in malignant melanoma: Continued strong overall survival in patients treated with UV1 cancer vaccine and pembrolizumab
-
NMD Pharma Initiates Phase 2b Trial of NMD670 in Generalized Myasthenia Gravis Patients
-
The net asset value of EfTEN Real Estate Fund AS shares as of 31.05.2024
-
Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates
-
Transactions in connection with share buyback programme
-
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared growth
-
Northwest China's Yangling setting benchmark for SCO agriculture technology cooperation for shared growth
-
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover Network
-
Flash News: OKX Announces Participation in Launch of Lagrange Labs' First Production-Ready ZK Prover Network
-
President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday
-
Anomalo Named Databricks Emerging Partner of the Year
-
AUTODESK ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Autodesk, Inc. and Encourages Investors to Contact the Firm
-
MARINUS ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Marinus Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
-
CAPREIT Announces Results of 2024 Annual General Meeting
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Teladoc Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TDOC
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Masimo Corporation Investors to Inquire About Securities Class Action Investigation – MASI
-
CoreCivic Receives Termination Notice From U.S. Immigration and Customs Enforcement At South Texas Family Residential Center
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Xiao-I Corporation Investors to Inquire About Securities Class Action Investigation – AIXI
-
INVESTOR DEADLINE NEXT WEEK: Robbins Geller Rudman & Dowd LLP Announces that Perion Network Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PERI
-
Centurion Acquisition Corp. Announces Pricing of $250 Million Initial Public Offering
-
True Exposure Investments, Inc. lowers management fee for series F of the TruX Exogenous Risk Pool and refiles Management Report of Fund Performance and Fund Facts documents for 2023
-
GICAI launches revolutionary global digital currency quantitative trading platform to improve investment returns and security
-
End of the BAPE Public Information Period
-
Bird to Acquire B.C.-Based Civil Infrastructure Contractor for $135 Million, Expects Resulting 10% Full Year Adj. EPS Accretion
-
Empower Healthcare Solutions and DispatchHealth® collaborate to bring in-home urgent medical care to Central Arkansas

